Yarra Oncology was established in 2014 by Dr Prasad Cooray. Prasad’s vision in establishing a dedicated cancer clinic was to amplify his capacity to advocate for patients and deliver best practice, patient-centred care. Under Prasad’s leadership, Yarra Oncology champions a highly individualised model of care that combines current and evolving treatment options, delivered by a team of likeminded professionals.
Prasad is a general oncologist with sub-speciality interest in the treatment of gastrointestinal cancer (colon, rectum, oesophagus, stomach); hepato-biliary cancer (pancreas, liver, gall bladder, bile duct); genitourinary cancer (prostate, kidney, bladder); and lung cancer.
Prasad graduated from Monash University (MBBS Hons) in 1996, having spent an additional undergraduate year in laboratory-based research leading to a Bachelor of Medical Science (Hons) degree, undergraduate research award and a number of publications on platelet functioning and cell signalling. He completed speciality training at Melbourne’s Peter MacCallum Cancer Centre and The Austin and Alfred Hospitals.
Patients under Prasad’s care benefit from his extensive network of medical specialists as well as his commitment to coordinating care across multiple specialities. Prasad is actively involved in cancer clinical trials as a co-investigator at Eastern Health. He participates in weekly multidisciplinary team meetings that make treatment decisions on the management of complex cancer cases.
For Prasad, oncology offers a very privileged opportunity: to treat, educate and empower his patients. He established Yarra Oncology in 2014, a dedicated cancer practice that amplifies Prasad’s capacity to advocate for cancer patients and deliver best practice cancer care.
In addition to working at Yarra Oncology, Dr Pellegrini holds a public hospital appointment at Eastern Health. She has an active interest in clinical research relating to breast cancer and is an investigator on numerous clinical trials.
Dr Pellegrini is a member of Breast Cancer Trials Australia, the American Society of Clinical Oncology, and the Medical Oncology Group of Australia.
Outside of medicine, Dr Pellegrini is a classical pianist, avid theatre goer and an accomplished home cook.
Sid worked as a consultant in neuro-oncology and GI cancers at Monash until December 2020 and is currently pursuing a laboratory-based PhD at the Olivia Newton-John Cancer Research Institute, investigating novel therapies in brain and other aggressive cancers.
An asset to Yarra Oncology because of his diverse skill set, Sid also completed a Master of Public Health and Health Promotion through Deakin University in 2010. Sid takes a patient-centric and evidence-based approach to his work, and views honest and empathetic communication as an essential component of cancer care.
Dr Ferraro holds a public hospital appointment at Eastern Health, and undertakes regular clinics at Maroondah Hospital and Yarra Ranges health, as well as inpatient care at Maroondah Hospital. She is involved in clinical trials through Eastern Health and actively encourages patient participation in clinical research.
She is a member of the Medical Oncology Group of Australia, the American Society of Clinical Oncology, and the Australasian Gastro-Intestinal cancer Trials Group.
Bringing a wealth of experience to Yarra Oncology, Dr. Uccellini spent four transformative years as a clinical research fellow at the cancer clinical trials unit in the Olivia Newton John Cancer Centre. His commitment to advancing medical knowledge aligns seamlessly with Yarra Oncology’s mission of integrated and patient-centric cancer care.
Dr. Uccellini’s proficiency in clinical trials is underscored by his ongoing roles at the esteemed Walter Eliza Hall Institute and the ANZUP organization. This aligns with Yarra Oncology’s dedication to participating in clinical trials for the betterment of patient outcomes and the advancement of cancer treatment.
A defining aspect of Dr. Uccellini’s approach is his emphasis on patient empowerment through education and understanding. This resonates profoundly with Yarra Oncology’s mission, which champions the patient as the owner of their health. His commitment to empowering patients aligns seamlessly with Yarra Oncology’s vision of creating a framework that prioritises trust, communication, and individualised care.
As Yarra Oncology continues its mission to redefine cancer care, Dr. Anthony Uccellini’s expertise and dedication to patient empowerment through education will undoubtedly contribute to our ongoing success in providing holistic, evidence-based, and patient-centred oncological care.
Mei Sim completed a laboratory-based PhD in bowel cancer genetics at Peter MacCallum Cancer Centre. She worked as a consultant at Peter MacCallum Cancer Centre until January 2020, in the Upper Gastro-Intestinal and Neuroendocrine Tumour service and in Early Drug Development (Phase 1) Clinical Trials.
She is a member of the Medical Oncology Group of Australia, the American Society of Clinical Oncology, and the European Society of Medical Oncology.